A Pilot Study on the Effects of ILARIS on Patients With Proliferative Diabetic Retinopathy (PDRP)
Phase of Trial: Phase I
Latest Information Update: 27 Nov 2015
At a glance
- Drugs Canakinumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 23 Nov 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 14 Mar 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 08 May 2012 New trial record